PACI, SABRINA
PACI, SABRINA
DIPARTIMENTO DI MEDICINA, CHIRURGIA E ODONTOIATRIA (attivo dal 01/01/1999 al 26/04/2012)
A case of glycogenosis type IB associated with MGUS
2011 E. Riva, M. Gasparri, I. Giulini Neri, S. Paci
Absence of severe recurrent infections in GSD IB
2008 S. Paci, M. Gasparri, I. Giulini Neri, G. Cagnoli, E. Salvatici, M. Giovannini
Acidi grassi polinsaturi a lunga catena (LCPUFA)
2007 S. Paci
Amino acid status 6 hours after the assumption of two amino acid preparations in PKU patients on diet-therapy
2007 M. Giovannini, D. Casero, S. Paci, M. Gasparri, S. El Oksha, M. Bonza, A.M. Lammardo, E. Salvatici, C. Agostoni
Assetto lipidico nei pazienti con glicogenosi: l'esperienza della Clinica Pediatrica dell'Ospedale San Paolo
2006 S. Paci, I. Giulini Neri, M. Gasparri, M. Torcoletti, M. Giovannini
Bone mass density and body composition measured with dexa in patient affected by hyperphenilalaninemia
2009 M. Giovannini, M. Bonza, S. Paci, D. Bertolotti, G. Cagnoli, E. Salvatici, E. Riva
Bone metabolism and hypovitaminosis D in patients affected by glycogen storage disease type I (GSD I)
2011 E. Riva, S. Pieretti, S. Paci, I. Giulini Neri, E. Salvatici, M. Giovannini
Bone mineral density (BMD) in patients affected by hyperphenylalanynemia (HPA) : effects of calcium integration and physical activity evaluated with dual energy x-ray absorptiometry (DEXA)
2011 E. Riva, E. Salvatici, V. Scelsa, G. Cagnoli, S. Vincenti, S. Paci, M. Giovannini
Bone mineralization in GSD I and III
2008 E. Riva, S. Paci, I. Giulini Neri, M. Gasparri, G. Cagnoli, M. Bonza, C. Agostoni
Bone mineralization in type 1 glycogen storage disease: a two years follow up study
2010 E. Riva, I. Giulini Neri, M. Gasparri, J. Scotti Gerber, E. Salvatici, D. Minghetti, G. Cagnoli, S. Paci
Breastfeeding in phenylketonuric (PKU) and hyperphenylalaninemic (HPA) infants : how and why
2012 M. Giovannini, S. Paci, A. Lops, E. Salvatici, E. Verduci, G. Banderali, E. Riva
Breastfeeding in phenylketonuric and hyperphenylalaninemic infants : how and why
2012 M. Giovannini, S. Paci, A. Lops, E. Salvatici, E. Verduci, G. Banderali, E. Riva
Cardiovascular risk factors in hyperphenylalaninemic children on dietary treatment : correlation between carotid intima-media thickness and docosaexahenoic acid supplementation
2013 E. Salvatici, C. Pederiva, M.E. Capra, S. Vincenti, S. Paci, M. Giovannini
Case report: GSD type 1. and pregnancy
2008 S. Paci, M. Gasparri, I. Giulini Neri, M. Bonza, E. Salvatici, M. Giovannini
Cataract and optic disk drusen in a patient with glycogenosis and di George syndrome: Clinical and molecular report
2017 D. Allegrini, S. Penco, A. Pece, A. Autelitano, G. Montesano, S. Paci, C. Montanari, A. Maver, B. Peterlin, G. Damante, L.M. Rossetti
Could neurological symptomatology precede an acute metabolic crisis in patient affected by propionic aciduria (PA)? A particular case report
2012 S. Paci, S. Vincenti, R. Selmi, E. Salvatici, E. Riva
Densità minerale ossea (BMD) nei pazienti affetti da iperfenilalaninemia (HPA): ruolo della supplementazione con calcio e dell'attività fisica
2011 E. Riva, E. Salvatici, S. Paci, V. Scelsa, S. Vincenti, M. Giovannini
Determinants of Plasma Docosahexaenoic Acid Levels and Their Relationship to Neurological and Cognitive Functions in PKU Patients: A Double Blind Randomized Supplementation Study
2018 H. Demmelmair, A. Macdonald, U. Kotzaeridou, P. Burgard, D. Gonzalez-Lamuno, E. Verduci, M. Ersoy, G. Gokcay, B. Alyanak, E. Reischl, W. Müller-Felber, F. Faber, U. Handel, S. Paci, B. Koletzko
Diagnosi differenziale delle linfoadenopatie
2008 S. Paci, M. Gasparri, M.E. Capra, S. El Oksha, S. Bellini
Diagnosticare la malattia di Fabry per curarla
2008 E. Salvatici, M. Bonza, S. Bellini, S. Paci, E. Riva